Cargando…

A risk model based on pyroptosis subtypes predicts tumor immune microenvironment and guides chemotherapy and immunotherapy in bladder cancer

Although immunotherapy has revolutionized bladder cancer (BLCA) therapy, only few patients demonstrate durable clinical benefits due to the heterogeneity. Emerging evidence has linked pyroptosis to shaping tumor microenvironment (TME) and predicting therapy response. However, the relationship betwee...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Tielin, Li, Sheng, Yu, Chao, Wu, Yuanbo, Long, Huimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744904/
https://www.ncbi.nlm.nih.gov/pubmed/36509838
http://dx.doi.org/10.1038/s41598-022-26110-4